Axsome Therapeutics News - AXSM

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Axsome Therapeutics Inc AXSM NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 87.60 0.00 0.00 0.00 87.60 06:59:32
more quote information »

Recent News

Date Time Source Heading
1/22/202007:00GLOBEAxsome Therapeutics Completes Patient Randomization in the..
1/13/202006:52DJNAxsome Inks License Pact With Pfizer on Narcolepsy,..
1/13/202006:00GLOBEAxsome Therapeutics Enters into Exclusive License Agreement..
12/30/201906:15GLOBEAxsome Therapeutics Announces AXS-07 Achieves Co-Primary and..
12/23/201916:19GLOBEAxsome Therapeutics Announces Closing of $200 Million Public..
12/19/201907:05GLOBEAxsome Therapeutics Announces Pricing of Public Offering of..
12/18/201916:01GLOBEAxsome Therapeutics Announces Proposed Public Offering of..
12/17/201907:00GLOBEAxsome Therapeutics Added to NASDAQ Biotechnology Index
12/16/201906:00GLOBEAxsome Therapeutics Announces AXS-05 Achieves Primary..
12/03/201906:00GLOBEAxsome Therapeutics Announces AXS-12 Achieves Primary..
11/21/201907:00GLOBEAxsome Therapeutics to Host Investor R&D Call with Key..
11/07/201917:08EDGARQuarterly Report (10-q)
11/07/201916:54EDGARCurrent Report Filing (8-k)
11/07/201907:19EDGARCurrent Report Filing (8-k)
11/07/201907:00GLOBEAxsome Therapeutics Reports Third Quarter 2019 Financial..
10/29/201907:00GLOBEAxsome Therapeutics to Report Third Quarter 2019 Financial..
10/28/201907:11EDGARCurrent Report Filing (8-k)
10/28/201907:06EDGARCurrent Report Filing (8-k)
10/28/201907:05GLOBEAxsome Therapeutics Announces Results of MINDSET Physician..
10/28/201907:00GLOBEAxsome Therapeutics Announces Continued Progress in Clinical..
10/21/201907:07EDGARCurrent Report Filing (8-k)
10/21/201907:00GLOBEAxsome Therapeutics Completes Patient Enrollment in the..
10/16/201907:14EDGARCurrent Report Filing (8-k)
10/16/201907:00GLOBEAxsome Therapeutics Announces Completion of Patient..
10/15/201916:46EDGARStatement of Changes in Beneficial Ownership (4)
10/15/201916:44EDGARStatement of Changes in Beneficial Ownership (4)
10/15/201916:43EDGARStatement of Changes in Beneficial Ownership (4)
10/02/201907:06EDGARCurrent Report Filing (8-k)
10/02/201907:00GLOBEAxsome Therapeutics to Provide Update on Continued Progress..
9/30/201907:17EDGARStatement of Changes in Beneficial Ownership (4)
9/06/201919:02EDGARStatement of Changes in Beneficial Ownership (4)
9/06/201919:01EDGARInitial Statement of Beneficial Ownership (3)
9/05/201907:08EDGARCurrent Report Filing (8-k)
9/05/201907:00GLOBEAxsome Therapeutics Presents Positive AXS-07 Phase 1 Trial..
9/04/201908:45NNWInnovative Drug-Delivery Systems Benefit Patients and..
9/03/201907:00GLOBEAxsome Therapeutics to Present at the Morgan Stanley 17th..
8/20/201907:07EDGARCurrent Report Filing (8-k)
8/20/201907:00GLOBEAxsome Therapeutics Appoints David Marek as Chief Commercial..
8/08/201907:18EDGARCurrent Report Filing (8-k)
8/08/201907:00GLOBEAxsome Therapeutics Reports Second Quarter 2019 Financial..
7/30/201907:00GLOBEAxsome Therapeutics To Report Second Quarter 2019 Financial..
7/29/201907:06EDGARCurrent Report Filing (8-k)
7/29/201907:00GLOBEAxsome Therapeutics Amends Silicon Valley Bank Loan..
7/11/201907:46EDGARCurrent Report Filing (8-k)
7/05/201907:01EDGARStatement of Changes in Beneficial Ownership (4)
7/01/201907:00GLOBEAxsome Therapeutics Added to Russell 3000® and Russell 2000®..
6/27/201907:19EDGARStatement of Changes in Beneficial Ownership (4)
6/24/201907:06EDGARCurrent Report Filing (8-k)
6/24/201907:00GLOBEAxsome Therapeutics Initiates GEMINI Phase 3 Trial of AXS-05..
6/12/201907:01EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »
Your Recent History
NASDAQ
AXSM
Axsome The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200129 12:14:33